PURE Bioscience, Inc.
PUREOTCConsumer Defensive● Active
$0.07
$-0.00(-2.67%)
Market Cap$7328533
P/E Ratio—
52W High$0.14
52W Low$0.04
PURE Bioscience, Inc. (PURE) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
PURE · earnings · updated Jun 9, 2026
Latest Earnings
Q1 FY2026Report Date: Mar 16, 2026EPS Actual
-$0.01
Revenue
$0.00B
Fiscal Period
Q1 FY2026
FY ends December
Report Date
Mar 16, 2026
After Market Close
PURE reports quarterly as a OTC-listed Household & Personal Products company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q2 FY2026 | Jun 16, 2026 | — | — | — | — | — | — |
| ◌ Q2 FY2026 | Jun 16, 2026 | — | — | — | — | — | — |
| — Q1 FY2026 | Mar 16, 2026 | — | -$0.01 | — | $0.00B | — | — |
| — Q4 FY2025 | Dec 15, 2025 | — | -$0.00 | — | $0.00B | — | — |
| — Q4 FY2025 | Oct 29, 2025 | — | -$0.01 | — | $0.00B | — | — |
| — Q2 FY2025 | Jun 16, 2025 | — | -$0.01 | — | $0.00B | — | — |
| — Q1 FY2025 | Mar 17, 2025 | — | -$0.01 | — | $0.00B | — | — |
| — Q4 FY2024 | Dec 16, 2024 | — | -$0.01 | — | $0.00B | — | — |
Q2 FY2026
Jun 16, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2026
Jun 16, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2026
Mar 16, 2026
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2025
Dec 15, 2025
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2025
Oct 29, 2025
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2025
Jun 16, 2025
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2025
Mar 17, 2025
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2024
Dec 16, 2024
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2012 | $-0.74 | $-0.62 | $-0.50 | 13 |
| Q2 FY2012 | $-0.36 | $-0.30 | $-0.24 | 17 |
| Q1 FY2012 | $-0.32 | $-0.26 | $-0.21 | 13 |
| Q3 FY2011 | $-0.67 | $-0.56 | $-0.45 | 14 |
| Q2 FY2008 | $-0.38 | $-0.32 | $-0.26 | 15 |
| Q1 FY2008 | $-0.58 | $-0.48 | $-0.38 | 17 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2012 | $0.1B | $0.2B | $0.2B | 13 |
| Q2 FY2012 | $0.1B | $0.1B | $0.1B | 17 |
| Q1 FY2012 | $0.0B | $0.0B | $0.0B | 13 |
| Q3 FY2011 | $0.1B | $0.2B | $0.2B | 14 |
| Q2 FY2008 | $0.1B | $0.1B | $0.2B | 15 |
| Q1 FY2008 | $0.1B | $0.1B | $0.1B | 17 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q1 FY2026 | Mar 16, 2026 | — | $0.08 | $0.08 | +1.98% |
| — Q4 FY2025 | Dec 15, 2025 | — | $0.05 | $0.05 | -5.96% |
| — Q4 FY2025 | Oct 29, 2025 | — | $0.08 | $0.08 | +0.00% |
| — Q2 FY2025 | Jun 16, 2025 | — | $0.08 | $0.08 | +0.00% |
| — Q1 FY2025 | Mar 17, 2025 | — | $0.07 | $0.07 | +1.74% |
| — Q4 FY2024 | Dec 16, 2024 | — | $0.07 | $0.06 | -9.57% |
| — Q4 FY2024 | Oct 29, 2024 | — | $0.10 | $0.09 | -4.89% |
| — Q2 FY2024 | Jun 14, 2024 | — | $0.07 | $0.07 | -3.27% |
Q1 FY2026+1.98%
Report Date
Mar 16, 2026
EPS Beat/Miss
—
Price Before
$0.08
Price After
$0.08
Q4 FY2025-5.96%
Report Date
Dec 15, 2025
EPS Beat/Miss
—
Price Before
$0.05
Price After
$0.05
Q4 FY2025+0.00%
Report Date
Oct 29, 2025
EPS Beat/Miss
—
Price Before
$0.08
Price After
$0.08
Q2 FY2025+0.00%
Report Date
Jun 16, 2025
EPS Beat/Miss
—
Price Before
$0.08
Price After
$0.08
Q1 FY2025+1.74%
Report Date
Mar 17, 2025
EPS Beat/Miss
—
Price Before
$0.07
Price After
$0.07
Q4 FY2024-9.57%
Report Date
Dec 16, 2024
EPS Beat/Miss
—
Price Before
$0.07
Price After
$0.06
Q4 FY2024-4.89%
Report Date
Oct 29, 2024
EPS Beat/Miss
—
Price Before
$0.10
Price After
$0.09
Q2 FY2024-3.27%
Report Date
Jun 14, 2024
EPS Beat/Miss
—
Price Before
$0.07
Price After
$0.07
Beat Rate0 / 8 quarters
Largest Move-9.57% (Q4 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: PURE ends December
PURE Bioscience, Inc. (PURE) most recently reported earnings on March 16, 2026 for Q1 FY2026, posting EPS of $-0.01 (in line with the analyst consensus of —). The next PURE earnings date is expected around September 1, 2026.
Each quarter, investors track PURE earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. PURE revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
PURE's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
PURE earnings · 4 questionsPURE Bioscience, Inc.'s next earnings report is expected around September 1, 2026. PURE typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; PURE historically reports after market close (AMC).
PURE earnings datewhen is PURE earningsPURE next earnings datewhen does PURE report earningsPURE earnings calendar
▸ Source: FMP · PURE Bioscience, Inc. SEC filings · US GAAP · PURE Bioscience, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026